Quince Therapeutics, Inc. short interest in 2025
In 2025, Quince Therapeutics, Inc.'s disclosed short interest ran from 5.91% of shares outstanding on 15 Jan 2025 to 4.70% on 31 Dec 2025, a change of -1.21 percentage points. The year's high was 6.02% on 31 Jan 2025 and its low 1.02% on 30 Jun 2025, averaging 2.92% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.76 days on 28 Feb 2025. Full history: Quince Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.91% (15 Jan 2025)
- End of year
- 4.70% (31 Dec 2025)
- Change
- -1.21 pp
- High
- 6.02% (31 Jan 2025)
- Low
- 1.02% (30 Jun 2025)
- Average
- 2.92%
- Highest days to cover
- 30.76 (28 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 5.91% | 18.25 | |
| 31 Jan 2025 | 6.02% | 23.32 | |
| 14 Feb 2025 | 5.83% | 19.94 | |
| 28 Feb 2025 | 5.77% | 30.76 | |
| 14 Mar 2025 | 3.84% | 11.52 | |
| 31 Mar 2025 | 3.49% | 14.06 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 3.22% | 9.16 | |
| 30 Apr 2025 | 2.40% | 9.37 | |
| 15 May 2025 | 1.37% | 1.00 | 10-Q filed, results (8-K) |
| 30 May 2025 | 1.15% | 2.57 | |
| 13 Jun 2025 | 1.08% | 1.38 | |
| 30 Jun 2025 | 1.02% | 1.45 | |
| 15 Jul 2025 | 1.68% | 2.68 | |
| 31 Jul 2025 | 2.02% | 5.33 | |
| 15 Aug 2025 | 1.73% | 3.56 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 1.67% | 7.35 | |
| 15 Sep 2025 | 1.62% | 7.37 | |
| 30 Sep 2025 | 1.66% | 3.37 | |
| 15 Oct 2025 | 2.47% | 2.27 | |
| 31 Oct 2025 | 2.44% | 6.25 | |
| 14 Nov 2025 | 2.45% | 2.70 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 2.79% | 1.42 | |
| 15 Dec 2025 | 3.71% | 1.71 | |
| 31 Dec 2025 | 4.70% | 5.23 |
See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.